Search Results for "Colchicine And Rivaroxaban"

05:48 EDT 1st August 2015 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Uninterrupted Rivaroxaban Feasible in AF Ablations, in Study

Event rates were low, but no major bleeding complications and no thromboembolic events occurred in the ablation group that had rivaroxaban maintained during the AF procedure. Heartwire from Meds...

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

Objective To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin.Design...

Trial Explores Rivaroxaban in Catheter Ablation

  Read more about Trial Explores Rivaroxaban in Catheter AblationComments

Janssen, Bayer initiate anticoagulant rivaroxaban trials

Janssen Pharmaceuticals and its development partner, Bayer HealthCare, have initiated CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patie...

NICE recommends Xarelto for blood clot prevention

In final guidance from the National Institute for Health and Care Excellence (NICE), it recommends Xarelto (rivaroxaban; Bayer) in combination with clopidogrel and aspirin, or with aspirin alone, as a...

Xarelto rivaroxaban regulatory update

Lupus Pericarditis Yields to Gout Drug (CME/CE)

(MedPage Today) -- Colchicine resolved pericarditis in a small French study of lupus patients.

Eye Bleeds: Risk from Warfarin Transition?

(MedPage Today) -- Three vitreous hemorrhage cases seen in patients during switch to rivaroxaban.

Matching PubMed Articles

Colchicine: Old and New.

Although colchicine has been a focus of research, debate and controversy for thousands of years, it was only approved by the United States Food and Drug Administration in 2009. Over the past decade, a...

Rivaroxaban does not impair fracture healing in a rat femur fracture model: an experimental study.

The prescription of the oral anticoagulant rivaroxaban to prevent thromboembolic episodes associated with orthopaedic surgery has dramatically increased since it was introduced. Rivaroxaban is beeing ...

Of men and meals.

Rivaroxaban is increasingly used to treat patients with acute venous thromboembolism (VTE), a potentially life-threatening condition. Since absorption of rivaroxaban decreases from nearly 100% to 66% ...

Association of Rivaroxaban Anticoagulation and Spontaneous Vitreous Hemorrhage.

Rivaroxaban is an anticoagulant prescribed for the management of atrial fibrillation. We describe a correlation between rivaroxaban and spontaneous vitreous hemorrhage.

Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry.

A biological rhythm in platelet function is well known. Multiple electrode aggregometry (MEA) is a widely used assay to measure platelet aggregability. Rivaroxaban is a new oral anticoagulant frequent...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement